ArticleTargeted oncology2014

Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.

Q Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.